Contraception
Oral contraceptive pretreatment assists in vitro fertilization
Published in Drug Week, February 10th, 2006
L. Rombauts and colleagues, Monash University, wrote, "This randomized controlled trial was designed to assess the impact of OC scheduling with a GnRH antagonist (ganirelix) regimen on the ovarian response of women undergoing recombinant FSH (rFSH) stimulation for IVF, compared with a non-scheduled ganirelix regimen and a long GnRH agonist (nafarelin) protocol."
"A total of 110 women was treated with an OC and ganirelix, 111 with ganirelix alone and 111 with nafarelin. The OC (containing 30 mcg ethinylestradiol/150 mcg desogestrel) was taken for...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2006-02-10)
More Articles from Drug Week
- Chlamydia Pneumonia
A novel phenoxazine derivative may be useful for controlling Chlamydia pneumoniae - Clarithromycin
Non-irradiated mice fared better with therapy for Bacillus anthracis Sterne infection - Drug Development
ACR16 receives orphan drug designation in the U.S. for Huntington disease - Drug Development
Approval granted to commence phase III study of Androxal for testosterone deficiency - Gene Expression
Neuropeptide gene expression in response to acute drug challenge may include modulation of behavioral effects - Acute Bacterial Sinusitis
Biopharma company submits NDA for Orapem to treat respiratory tract and skin infections - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
